BackSyros Pharmaceuticals Overview

Syros Pharmaceuticals Current Cash

Syros Pharmaceuticals's current cash is $58M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$58.27M
48.07% YoYΔ $-53.94M vs prior year quarter

Peer average

Loading

Syros Pharmaceuticals Current Cash History

Loading

Syros Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Syros Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Syros Pharmaceuticals (SYRS) FAQ

As of the most recent data (September 2024), SYRS shows a current cash of $58M. That compares with $110M in the prior-year period — down 48.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SYRS's current cash is now $58M (was $110M) — a 48.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Syros Pharmaceuticals is outperforming or lagging.

Tracking SYRS's current cash over time shows whether Syros Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $58M That compares with $110M in the prior-year period — down 48.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Syros Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $58M) with ownership activity and broader fundamentals.

Syros Pharmaceuticals's current cash is $58M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.